IE
EVLO

Israel Englander’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Israel Englander’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-38,093
Closed -$149K – 6863
2023
Q3 		$149K Buy
+38,093
New +$260K ﹤0.01% 5222
2023
Q2 		– Sell
-2,921
Closed -$11K – 6987
2023
Q1 		$11K Sell
2,921
-1,771
-38% -$27.3K ﹤0.01% 6019
2022
Q4 		$151K Sell
4,692
-4,541
-49% -$180K ﹤0.01% 5437
2022
Q3 		$386K Sell
9,233
-424
-4% -$19.4K ﹤0.01% 5180
2022
Q2 		$408K Buy
9,657
+7,481
+344% +$347K ﹤0.01% 5116
2022
Q1 		$148K Sell
2,176
-3,247
-60% -$270K ﹤0.01% 5976
2021
Q4 		$658K Buy
5,423
+4,473
+471% +$755K ﹤0.01% 4802
2021
Q3 		$134K Sell
950
-1,577
-62% -$312K ﹤0.01% 6302
2021
Q2 		$694K Sell
2,527
-3,713
-60% -$937K ﹤0.01% 5001
2021
Q1 		$1.33M Buy
6,240
+4,245
+213% +$1.17M ﹤0.01% 3913
2020
Q4 		$482K Sell
1,995
-5,612
-74% -$694K ﹤0.01% 4227
2020
Q3 		$802 Buy
7,607
+6,321
+492% +$576K ﹤0.01% 3292
2020
Q2 		$126K Buy
1,286
+715
+125% +$62.6K ﹤0.01% 3946
2020
Q1 		$43K Buy
+571
New +$54.4K ﹤0.01% 3679

Other funds holding EVLO

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Israel Englander's EVLO Position: Q4 2023 in Review

Israel Englander sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q4 2023, closing a stake of 38,093 shares — an estimated $149K sold.

Israel Englander first reported a position in EVLO in Q1 2020 and held it in 14 quarters. The position peaked at $1.33M in Q1 2021. 2 funds tracked by Wall St. Rank hold EVLO as of Q4 2023.

  • Israel Englander reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Israel Englander sold 38,093 Evelo Biosciences, Inc. Common Stock shares in Q4 2023, an estimated $149K.
  • Israel Englander first reported a position in Evelo Biosciences, Inc. Common Stock in Q1 2020 and held it in 14 quarters.
  • Israel Englander's Evelo Biosciences, Inc. Common Stock position peaked at $1.33M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.